已收盘 11-20 16:00:00 美东时间
-0.080
-0.24%
Lakefront Biotherapeutics NV ((Euronext &, NASDAQ:LKFT) announced that its Board of Directors has created 150,000 subscription rights under a new subscription right plan on November 10, 2026.On November 10, 2026,
11-19 05:04
Lakefront Biotherapeutics (NASDAQ:LKFT) reported quarterly losses of €(0.04) per share which beat the analyst consensus estimate of €(0.19) by 78.95 percent. This is a 98.7 percent increase over losses of €(3.07) per
11-12 05:13
U.S. stocks fell Wednesday, led by a 1.1% Nasdaq drop. Cintas beat estimates and raised guidance; oil gained while gold, silver and copper declined.
09-24 02:08